During the past 12 months, Asian Phytoceuticals PCL's average EPS without NRIGrowth Rate was 7.40% per year.
During the past 3 years, the average EPS without NRIGrowth Rate was -15.50% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was -5.30% per year.
During the past 10 years, the average EPS without NRIGrowth Rate was -7.60% per year.
During the past 13 years, Asian Phytoceuticals PCL's highest 3-Year average EPS without NRI Growth Rate was 19.60% per year. The lowest was -23.40% per year. And the median was -7.70% per year.
Asian Phytoceuticals PCL (BKK:APCO-R) Earnings per Share (Diluted) Explanation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Asian Phytoceuticals PCL Earnings per Share (Diluted) Related Terms
Asian Phytoceuticals PCL Earnings per Share (Diluted) Historical Data
* Premium members only.
The historical data trend for Asian Phytoceuticals PCL's Earnings per Share (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Asian Phytoceuticals PCL Earnings per Share (Diluted) Chart
BKK:APCO-R vs PG, CL, KVUE: Earnings per Share (Diluted) Comparison
For the Household & Personal Products subindustry, Asian Phytoceuticals PCL's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Asian Phytoceuticals PCL PE Ratio vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Asian Phytoceuticals PCL's PE Ratio distribution charts can be found below:
* The bar in red indicates where Asian Phytoceuticals PCL's PE Ratio falls into.
Asian Phytoceuticals PCL Earnings per Share (Diluted) Calculation
Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.
Asian Phytoceuticals PCL's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2025 is calculated as
Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿0.09
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.
What does a Earnings per Share (Diluted) of ฿0.09 mean?
Asian Phytoceuticals PCL (BKK:APCO-R) has a Earnings per Share (Diluted) of ฿0.09 as of Mar. 2026. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Asian Phytoceuticals PCL and its competitors. According to the industry distribution chart, Asian Phytoceuticals PCL ranks #1186 out of 1524 companies in the Consumer Packaged Goods industry, placing it in the top 77.8%.
Is Asian Phytoceuticals PCL's Earnings per Share (Diluted) too high?
Asian Phytoceuticals PCL's current Earnings per Share (Diluted) is ฿0.09. Based on the distribution chart, Asian Phytoceuticals PCL ranks #1186 out of 1524 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Asian Phytoceuticals PCL has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does Asian Phytoceuticals PCL's Earnings per Share (Diluted) compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Asian Phytoceuticals PCL ranks #1186 out of 1524 companies for Earnings per Share (Diluted). This places Asian Phytoceuticals PCL in the lower half of its industry. The industry median Earnings per Share (Diluted) is 7.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings per Share (Diluted) for a Consumer Packaged Goods company?
The median Earnings per Share (Diluted) among Consumer Packaged Goods companies is 7.40, based on 1,524 companies in the industry. Companies in the top quartile (top 25%) have a Earnings per Share (Diluted) significantly above this median, while those in the bottom quartile fall well below. However, Earnings per Share (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings per Share (Diluted) mean?
A high Earnings per Share (Diluted) can signal that a stock is expensive relative to its fundamentals. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Asian Phytoceuticals PCL and its competitors. For the Consumer Packaged Goods industry, the median Earnings per Share (Diluted) is 7.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Asian Phytoceuticals PCL's current Earnings per Share (Diluted) is ฿0.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asian Phytoceuticals PCL stock overvalued right now?
Asian Phytoceuticals PCL (BKK:APCO-R) has a current Earnings per Share (Diluted) of ฿0.09. The stock's GF Value™ is ฿7.61, compared to a current price of ฿6.27 — trading 17.6% below its estimated fair value. The current Earnings per Share (Diluted) is ฿0.09. Asian Phytoceuticals PCL's overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings per Share (Diluted) calculated?
Earnings per Share (Diluted) is calculated from a company's financial statements. For Asian Phytoceuticals PCL (BKK:APCO-R), the current Earnings per Share (Diluted) is ฿0.09 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Asian Phytoceuticals PCL (BKK:APCO-R) Overvalued in 2026?
Based on GuruFocus' analysis, Asian Phytoceuticals PCL stock appears to be undervalued.
The current stock price of ฿6.27 is trading 17.6% below its estimated GF Value™ of ฿7.61.
Key valuation signals for BKK:APCO-R:
Earnings per Share (Diluted): ฿0.09
GF Value™: ฿7.61 vs. price of ฿6.27 (17.6% below fair value)
No single metric tells the full story. See the BKK:APCO-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Asian Phytoceuticals PCL engages in the manufacturing and marketing of herbal healthcare products. The company engages in the production and distribution of dietary supplements, cosmetics, and personal care products made from natural herbs. Its beauty products include skin nourishing and skin care products, hair loss treatment and hair growth products, slimming products, dietary supplements, and other nutritional products. Geographically, the company offers its services only in Thailand.
62GF Score
Get the complete analysis for BKK:APCO-R
Earnings per Share (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:APCO-R has been successfully added to your 
